InvestSMART

Regis Healthcare Limited (ASX: REG) - Announcements

Current share price for REG : $4.430 0.06 (1.37%)+

ASX company news and announcements for Regis Healthcare Limited (REG) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Regis Healthcare Limited (REG) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Regis Healthcare Limited (REG), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Regis Healthcare Limited (REG)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$1,340 Non-Cash Impact of Removal of Aged Care Approval Rounds 13 Dec 2021 9:47AM $1.720 $4.430 risen by 157.56%
$1,340 Notification regarding unquoted securities - REG 29 Nov 2021 9:04AM $1.790 $4.430 risen by 147.49%
$1,340 Notification regarding unquoted securities - REG 24 Nov 2021 3:33PM $1.860 $4.430 risen by 138.17%
$1,340 Change Of Director's Interest Notice 24 Nov 2021 3:27PM $1.865 $4.430 risen by 137.53%
$1,340 Final Director's Interest Notice 28 Oct 2021 9:44AM $1.960 $4.430 risen by 126.02%
$1,340 Final Director's Interest Notice 28 Oct 2021 9:44AM $1.960 $4.430 risen by 126.02%
$1,340 Appointment of Company Secretary 27 Oct 2021 10:07AM $2.000 $4.430 risen by 121.50%
$1,340 Regis Healthcare - Results Of Annual General Meeting 26 Oct 2021 1:19PM $2.015 $4.430 risen by 119.85%
$1,340 Regis Healthcare - Chairman And MD Addresses To AGM 26 Oct 2021 9:41AM $2.020 $4.430 risen by 119.31%
$1,340 Application for quotation of securities - REG 28 Sep 2021 11:14AM $2.070 $4.430 risen by 114.01%
$1,340 Annual Report To Shareholders 23 Sep 2021 12:23PM $2.120 $4.430 risen by 108.96%
$1,340 Notice of Annual General Meeting/Proxy Form 23 Sep 2021 12:14PM $2.120 $4.430 risen by 108.96%
$1,340 Appendix 4G And Corporate Governance Statement 23 Sep 2021 12:12PM $2.120 $4.430 risen by 108.96%
$1,340 Regis Healthcare Investor Presentation FY2021 Results 31 Aug 2021 8:14AM $1.970 $4.430 risen by 124.87%
$1,340 Regis Healthcare Results Announcement FY2021 31 Aug 2021 8:13AM $1.970 $4.430 risen by 124.87%
$1,340 Dividend/Distribution - REG 31 Aug 2021 8:12AM $1.970 $4.430 risen by 124.87%
$1,340 Regis Healthcare Appendix 4E and Financial Report FY2021 31 Aug 2021 8:12AM $1.970 $4.430 risen by 124.87%
$1,340 AGM Date 16 Aug 2021 9:07AM $1.960 $4.430 risen by 126.02%
$1,340 Statement regarding Employee Underpayments 9 Aug 2021 8:14AM $2.100 $4.430 risen by 110.95%
$1,340 Notification of FY21 Full Year Results Date 26 Jul 2021 12:00PM $1.930 $4.430 risen by 129.53%
$1,340 Change of Company Secretary 15 Jul 2021 12:59PM $1.978 $4.430 risen by 124.02%
$1,340 Dividend/Distribution - REG 24 Feb 2021 8:46AM $1.940 $4.430 risen by 128.35%
$1,340 Regis Healthcare Investor Presentation 1H FY21 Results 24 Feb 2021 8:37AM $1.940 $4.430 risen by 128.35%
$1,340 Regis Healthcare Results Announcement 1H FY21 24 Feb 2021 8:33AM $1.940 $4.430 risen by 128.35%
$1,340 Regis Healthcare 4D and Financial Report 1H FY21 24 Feb 2021 8:32AM $1.940 $4.430 risen by 128.35%

201 - 225 of 406 results

Page 9 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.